We are live on ! Find out more
TTOO

T2 Biosystems, Inc

Delisted

TTOO was delisted on the 11th of February, 2025.

89 hedge funds and large institutions have $203M invested in T2 Biosystems, Inc in 2018 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

550% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 8

98% more funds holding

Funds holding: 4589 (+44)

70% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 10

65% more capital invested

Capital invested by funds: $123M → $203M (+$80.3M)

61% more call options, than puts

Call options by funds: $2.36M | Put options by funds: $1.47M

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
89
Holders Change
+44
Holders Change %
+97.78%
% of All Funds
2.04%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
52
Increased
17
Reduced
10
Closed
8
Calls
$2.36M
Puts
$1.47M
Net Calls
+$895K
Net Calls Change
+$915K
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$33.2M +$75.9K +2 +0.2%
SM
2
Senvest Management
New York
$20.6M -$228K -6 -1%
PVMCV
3
Polaris Venture Management Co V
Massachusetts
$14.3M -$266K -7 -2%
BlackRock
4
BlackRock
New York
$14.1M +$12.6M +333 +1,041%
Vanguard Group
5
Vanguard Group
Pennsylvania
$11.6M +$4.1M +108 +57%
Morgan Stanley
6
Morgan Stanley
New York
$11M -$1.14M -30 -10%
Millennium Management
7
Millennium Management
New York
$9.11M +$6.76M +178 +312%
TM
8
Tiger Management
New York
$7.79M -$7.7M -203 -50%
LIM
9
Lagoda Investment Management
New York
$7.39M -$6.3M -166 -46%
Renaissance Technologies
10
Renaissance Technologies
New York
$6.36M +$4.93M +130 +382%
AAP
11
Ardsley Advisory Partners
Connecticut
$5.84M +$5.73M +151 New
EIM
12
Essex Investment Management
Massachusetts
$5.26M +$152K +4 +3%
JP Morgan Chase
13
JP Morgan Chase
New York
$4.75M +$3.64M +96 +356%
State Street
14
State Street
Massachusetts
$3.07M +$2.81M +74 +1,480%
Fuller & Thaler Asset Management
15
Fuller & Thaler Asset Management
California
$2.95M
Allianz Asset Management
16
Allianz Asset Management
Germany
$2.92M +$2.85M +75 New
Wells Fargo
17
Wells Fargo
California
$2.75M +$2.66M +70 +7,000%
EMFAT
18
Emerald Mutual Fund Advisers Trust
Pennsylvania
$2.71M +$2.66M +70 New
Point72 Asset Management
19
Point72 Asset Management
Connecticut
$2.61M +$1.44M +38 +127%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$2.57M +$1.48M +39 +144%
Deutsche Bank
21
Deutsche Bank
Germany
$2.55M +$2.24M +59 +843%
Northern Trust
22
Northern Trust
Illinois
$2.42M +$1.94M +51 +464%
Alyeska Investment Group
23
Alyeska Investment Group
Illinois
$2.37M +$2.31M +61 New
BRC
24
Bell Rock Capital
Delaware
$1.86M +$417K +11 +30%
EI
25
EAM Investors
California
$1.63M +$1.59M +42 New

TTOO Hedge Fund Activity: Q2 2018 in Review

89 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q2 2018, worth a combined $203M — up 65% from $123M a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new TTOO positions and 8 closed out — a net gain of 44 holders — while 17 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock, adding an estimated $12.6M. The largest seller was Tiger Management, cutting an estimated $7.7M.

  • 89 institutional investors held T2 Biosystems, Inc (TTOO) as of Q2 2018, up from 45 in Q1 2018.
  • Funds reported $203M of T2 Biosystems, Inc stock for Q2 2018, up 65% quarter-over-quarter.
  • 52 funds opened new T2 Biosystems, Inc positions in Q2 2018 and 8 closed out, a net change of +44 holders.
  • The largest T2 Biosystems, Inc buyer in Q2 2018 was BlackRock, an estimated $12.6M added.
  • The largest T2 Biosystems, Inc seller in Q2 2018 was Tiger Management, an estimated $7.7M sold.

Based on aggregated 13F filings for Q2 2018.